Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer cells ’’commit suicide’’

30.09.2003


Catalysts which cause cancer cells to ’’commit suicide’’ have been developed in the laboratory by West Country scientists.



The research groups of Dr Claus Jacob, of Exeter University and Dr Nicholas Gutowski at the Royal Devon and Exeter Hospital, with support from the Peninsula Medical School, are investigating the anti-cancer effects of biocatalysts that mimic the activity of the human selenium enzyme, glutathione peroxidase. Their work opens up a very promising new direction for anti-cancer research, but both stress that any potential treatment for sufferers is still many years away.

Dr Jacob, of the University’’s School of Biological and Chemical Sciences, explained: ’’The catalysts work by initiating reactions inside the cancer cell that cause it to destroy itself. In effect, the cancer commits
suicide. One of the benefits of this approach is that the drugs target only the diseased cells.


The research opens up the possibility in the future of an entirely new way of treating cancer that has two advantages over conventional treatments:

1. The catalysts use the particular makeup of cancer cells for their activity and thus do not work in healthy cells. This means they are far more targeted than conventional drugs and could potentially avoid many of the unpleasant side effects associated with chemotherapy and radiotherapy.

2. Catalysts are not consumed during their activity but are recycled over and over again. This means that only minute quantities of biocatalyst are needed to kill cancer cells making them highly efficient.

Dr Jacob said: ’’Cancer therapy has long been based on highly toxic substances that randomly kill healthy and sick cells alike. This new approach might allow us to single out sick cells and kill them with a catalytic efficiency far superior to conventional radiation or chemotherapy. The experimental results obtained so far have been truly impressive but further evaluation and clinical trials are required to develop this.’’

The compounds have been developed and synthesised at the University’’s School of Biological and Chemical Sciences and tested in cancer cells at the Royal Devon and Exeter Hospital. The work has been partially funded by the Leverhulme Trust. An Exeter based company has already shown an interest in the compounds and the new method. The most active compound tested so far is a multifunctional catalyst that integrates a quinone with a chalcogen redox system in one chemically simple molecule.

Claus Jacob | alfa

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>